Cargando…

The Value of CT Attenuation in Distinguishing Atypical Adenomatous Hyperplasia from Adenocarcinoma in Situ

BACKGROUND AND OBJECTIVE: Advances in high-resolution computed tomography (CT) scanning have increased the detection of small ground-glass opacity (GGO) nodules and also allowed such images to be investigated in detail. However, it is difficult to differentiate atypical adenomatous hyperplasia (AAH)...

Descripción completa

Detalles Bibliográficos
Autores principales: JIANG, Binghu, WANG, Jichen, JIA, Peng, LE, Meizhao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 中国肺癌杂志编辑部 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6000614/
https://www.ncbi.nlm.nih.gov/pubmed/24229623
http://dx.doi.org/10.3779/j.issn.1009-3419.2013.11.03
_version_ 1783331787945017344
author JIANG, Binghu
WANG, Jichen
JIA, Peng
LE, Meizhao
author_facet JIANG, Binghu
WANG, Jichen
JIA, Peng
LE, Meizhao
author_sort JIANG, Binghu
collection PubMed
description BACKGROUND AND OBJECTIVE: Advances in high-resolution computed tomography (CT) scanning have increased the detection of small ground-glass opacity (GGO) nodules and also allowed such images to be investigated in detail. However, it is difficult to differentiate atypical adenomatous hyperplasia (AAH) from adenocarcinoma in situ (AIS) with CT, even at follow-up, because they share many similar CT manifestations. While AAH is thought to be a precursor or even an early-stage lesion of lung adenocarcinoma, and the stepwise progression from AAH to AIS is thought to be reasonable. Therefore, the hypothesis that the attenuation of GGO is increased gradually from AAH to AIS is proposed. The aim of this study was to distinguish AAH from AIS with CT attenuation in patients with pure GGO nodules. METHODS: Between January 2010 and December 2012, the CT findings in terms of the greatest diameter and mean CT attenuation (HU) were reviewed and correlated with pathology in 56 patients with AAH (n=21) and non-mucinous AIS (n=38) by two independent observers. All the 59 lesions were pure GGO nodules with size of 2 cm or smaller. To determine variability of measuring CT attenuation, we calculated the 95% confidence interval (CI) for the limits of agreement by using Bland-Altman analysis. Student t test was used to compare AAH and AIS in terms of diameter and CT attenuation. And receiver operating characteristic (ROC) curve was used to determine the optimal cut-off value of mean CT attenuation for differentiating AAH from AIS and obtain the diagnostic value. Two-tailed P value of less than 0.05 was considered to be significant. RESULTS: For the manually measured CT attenuation, the 95%CI for the limits of agreement was -40 HU, 50 HU for inter-observer variability. Although there was significant difference in nodule diameter between AAH and AIS (P=0.046), the overlap was considerable. The mean CT attenuation was (-718±53) HU (95%CI: -822, -604) for AAH, which was significantly smaller than (-600±35) HU (95%CI: -669, -531) for AIS (P=0.013). The area under curve (AUC) from ROC was 0.903 for differentiating AAH from AIS, and the cut-off value of -632 HU was optimal for differentiation between AAH and AIS, with sensitivity of 0.79, specificity of 0.95, and accuracy of 0.85. CONCLUSION: The mean CT attenuation can help the radiological differentiation between AAH and AIS.
format Online
Article
Text
id pubmed-6000614
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher 中国肺癌杂志编辑部
record_format MEDLINE/PubMed
spelling pubmed-60006142018-07-06 The Value of CT Attenuation in Distinguishing Atypical Adenomatous Hyperplasia from Adenocarcinoma in Situ JIANG, Binghu WANG, Jichen JIA, Peng LE, Meizhao Zhongguo Fei Ai Za Zhi Clinical Research BACKGROUND AND OBJECTIVE: Advances in high-resolution computed tomography (CT) scanning have increased the detection of small ground-glass opacity (GGO) nodules and also allowed such images to be investigated in detail. However, it is difficult to differentiate atypical adenomatous hyperplasia (AAH) from adenocarcinoma in situ (AIS) with CT, even at follow-up, because they share many similar CT manifestations. While AAH is thought to be a precursor or even an early-stage lesion of lung adenocarcinoma, and the stepwise progression from AAH to AIS is thought to be reasonable. Therefore, the hypothesis that the attenuation of GGO is increased gradually from AAH to AIS is proposed. The aim of this study was to distinguish AAH from AIS with CT attenuation in patients with pure GGO nodules. METHODS: Between January 2010 and December 2012, the CT findings in terms of the greatest diameter and mean CT attenuation (HU) were reviewed and correlated with pathology in 56 patients with AAH (n=21) and non-mucinous AIS (n=38) by two independent observers. All the 59 lesions were pure GGO nodules with size of 2 cm or smaller. To determine variability of measuring CT attenuation, we calculated the 95% confidence interval (CI) for the limits of agreement by using Bland-Altman analysis. Student t test was used to compare AAH and AIS in terms of diameter and CT attenuation. And receiver operating characteristic (ROC) curve was used to determine the optimal cut-off value of mean CT attenuation for differentiating AAH from AIS and obtain the diagnostic value. Two-tailed P value of less than 0.05 was considered to be significant. RESULTS: For the manually measured CT attenuation, the 95%CI for the limits of agreement was -40 HU, 50 HU for inter-observer variability. Although there was significant difference in nodule diameter between AAH and AIS (P=0.046), the overlap was considerable. The mean CT attenuation was (-718±53) HU (95%CI: -822, -604) for AAH, which was significantly smaller than (-600±35) HU (95%CI: -669, -531) for AIS (P=0.013). The area under curve (AUC) from ROC was 0.903 for differentiating AAH from AIS, and the cut-off value of -632 HU was optimal for differentiation between AAH and AIS, with sensitivity of 0.79, specificity of 0.95, and accuracy of 0.85. CONCLUSION: The mean CT attenuation can help the radiological differentiation between AAH and AIS. 中国肺癌杂志编辑部 2013-11-20 /pmc/articles/PMC6000614/ /pubmed/24229623 http://dx.doi.org/10.3779/j.issn.1009-3419.2013.11.03 Text en 版权所有©《中国肺癌杂志》编辑部2013 https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 3.0) License. See: https://creativecommons.org/licenses/by/3.0/
spellingShingle Clinical Research
JIANG, Binghu
WANG, Jichen
JIA, Peng
LE, Meizhao
The Value of CT Attenuation in Distinguishing Atypical Adenomatous Hyperplasia from Adenocarcinoma in Situ
title The Value of CT Attenuation in Distinguishing Atypical Adenomatous Hyperplasia from Adenocarcinoma in Situ
title_full The Value of CT Attenuation in Distinguishing Atypical Adenomatous Hyperplasia from Adenocarcinoma in Situ
title_fullStr The Value of CT Attenuation in Distinguishing Atypical Adenomatous Hyperplasia from Adenocarcinoma in Situ
title_full_unstemmed The Value of CT Attenuation in Distinguishing Atypical Adenomatous Hyperplasia from Adenocarcinoma in Situ
title_short The Value of CT Attenuation in Distinguishing Atypical Adenomatous Hyperplasia from Adenocarcinoma in Situ
title_sort value of ct attenuation in distinguishing atypical adenomatous hyperplasia from adenocarcinoma in situ
topic Clinical Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6000614/
https://www.ncbi.nlm.nih.gov/pubmed/24229623
http://dx.doi.org/10.3779/j.issn.1009-3419.2013.11.03
work_keys_str_mv AT jiangbinghu thevalueofctattenuationindistinguishingatypicaladenomatoushyperplasiafromadenocarcinomainsitu
AT wangjichen thevalueofctattenuationindistinguishingatypicaladenomatoushyperplasiafromadenocarcinomainsitu
AT jiapeng thevalueofctattenuationindistinguishingatypicaladenomatoushyperplasiafromadenocarcinomainsitu
AT lemeizhao thevalueofctattenuationindistinguishingatypicaladenomatoushyperplasiafromadenocarcinomainsitu
AT jiangbinghu valueofctattenuationindistinguishingatypicaladenomatoushyperplasiafromadenocarcinomainsitu
AT wangjichen valueofctattenuationindistinguishingatypicaladenomatoushyperplasiafromadenocarcinomainsitu
AT jiapeng valueofctattenuationindistinguishingatypicaladenomatoushyperplasiafromadenocarcinomainsitu
AT lemeizhao valueofctattenuationindistinguishingatypicaladenomatoushyperplasiafromadenocarcinomainsitu